By Rachel Turow, Samuel Cammer and Leslie Demers ( September 30, 2026, 3:31 PM EDT) -- A significant uptick has occurred in mergers and acquisitions in the biosimilars sector, with deal value approximating $13 billion in the first nine months of 2026 alone, and mimicking the 15% year-over-year increase since 2025 in the biopharmaceutical sector's average transaction size....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.